1. Home
  2. XXII vs ALZN Comparison

XXII vs ALZN Comparison

Compare XXII & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 22nd Century Group Inc.

XXII

22nd Century Group Inc.

HOLD

Current Price

$2.17

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$1.10

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XXII
ALZN
Founded
1998
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.8M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
XXII
ALZN
Price
$2.17
$1.10
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
46.1K
152.0K
Earning Date
05-12-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
69.96
22.99
EPS
N/A
N/A
Revenue
$25,832,530.00
N/A
Revenue This Year
$370.28
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.67
$0.51
52 Week High
$11.37
$8.22

Technical Indicators

Market Signals
Indicator
XXII
ALZN
Relative Strength Index (RSI) 39.35 40.48
Support Level $2.18 $0.84
Resistance Level $2.67 $2.57
Average True Range (ATR) 0.24 0.09
MACD 0.06 0.04
Stochastic Oscillator 74.32 87.10

Price Performance

Historical Comparison
XXII
ALZN

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: